Biosceptre
is engaged in the development and commercialization of monoclonal antibody therapeutics for the treatment of cancer... Read moreBiosceptre
is engaged in the development and commercialization of monoclonal antibody therapeutics for the treatment of cancer... Read more
News
Sep 05, 2018
BioPortfolio
Biosceptre: Biosceptre International Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13042018 Prices from USD $250
Aug 21, 2018
PR Newswire
Press Release: Biosceptre : Initiation of Biosceptre's Phase 1 Clinical Trial for First-in-Class Oncology Vaccine BIL06v
Nov 26, 2017
BioPortfolio
Biosceptre: Biosceptre International Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 08112017 Prices from USD $250
Jul 26, 2017
BioPortfolio
Biosceptre: Biosceptre International Ltd Medical Equipment Deals and Alliances Profile Report Updated 11072017 Prices from USD $250
Jun 13, 2017
Biosceptre Blog
Biosceptre Blog Biosceptre Joins European Cooperation in Science & Technology COST Group BMBS 1406 - with focus on Ion Channels and Immune Response
Apr 04, 2017
BioPortfolio
Biosceptre: Biosceptre International Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Updated 23032017 Prices from USD $250
Mar 16, 2017
Biosceptre Blog
Biosceptre Blog Biosceptre's Phase 1 Clinical Trial for anti-cancer antibody BIL03s approved by Ethics Committee
Mar 03, 2017
Biosceptre Blog
Biosceptre Blog Biosceptre publishes a clinical study of topical drug BIL010t as therapy for BCC
Dec 28, 2016
BriefingWire
Press Release: Biosceptre : Biosceptre (Aust) Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Dec 03, 2016
BioPortfolio
Biosceptre: Biosceptre Aust Pty Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
Biosceptre Competitors
1
2
3
4
5
6
7
8
9
10